[1] Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300. DOI: 10.3322/caac.20073.
[2] Fayers P, Bottomley A, EORTC Quality of Life Group, et al, Quality of life research within the EORTCthe EORTC QLQC30. European Organisation for Research and Treatment of Cancer[J]. Eur J Cancer, 2002, 38 Suppl 4: S125-133.
[3] Chen W, Lu Y, Wu J, et al. Betaelemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factormediated angiogenesis[J]. Cancer Chemother Pharmacol, 2011, 67 (4): 799-808. DOI: 10.1007/s002800101378x.
[4] Dong Y, Li L, Wang L, et al. Preliminary study of the effects of βelemene on MCF7/ADM breast cancer stem cells[J]. Genet Mol Res, 2015, 14(1): 2347-2355. DOI: 10.4238/2015.March.27.20.
[5] Liu JS, Chen XM, Chang S, et al. βelemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation[J]. World J Gastroenterol, 2015, 21(34): 9945-9956. DOI: 10.3748/wjg.v21.i34.9945.
[6] Lee RX, Li QQ, Reed E. βelemene effectively suppresses the growth and survival of both platinumsensitive and resistant ovarian tumor cells[J]. Anticancer Res, 2012, 32(8): 3103-3113.
[7] Zou K, Liu C, Zhang Z, et al. The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism[J]. Clinics (Sao Paulo), 2015, 70(8): 556-562. DOI: 10.6061/clinics/2015(08)05.
[8] Li QQ, Lee RX, Liang H, et al. βElemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC1 and XIAP and inactivation of JNK[J]. Int J Oncol, 2013, 43(3): 721-728. DOI: 10.3892/ijo.2013.1996.
[9] Tan W, Lu J, Huang M, et al. Anticancer natural products isolated from Chinese medicinal herbs[J]. Chin Med, 2011, 6(1): 27. DOI: 10.1186/17498546627.
[10] Wang G, Li X, Huang F, et al. Antitumor effect of betaelemene in nonsmallcell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death[J]. Cell Mol Life Sci, 2005, 62(7-8): 881-893.
[11] 田欣, 张振勇, 吴荣. 榄香烯治疗不能耐受放化疗的恶性肿瘤临床观察[J]. 世界中西医结合杂志, 2014, 9(9): 978-979, 995. DOI: 10.13935/j.cnki.sjzx.140923.
[12] Jiang ZY, Qin SK, Yin XJ, et al. Synergistic effects of Endostar combined with βelemene on malignant ascites in a mouse model[J]. Exp Ther Med, 2012, 4(2): 277-284.
[13] 夏婷, 于爱军. 晚期卵巢癌的巩固或维持治疗[J]. 国际肿瘤学杂志, 2014, 41(1): 60-62. DOI: 10.3760/cma.j.issn.1673422X.2014.01.019.
[14] Wright AA, Cronin A, Milne DE, et al. Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer[J]. J Clin Oncol, 2015, 33(26): 2841-2847. DOI: 10.1200/JCO.2015.61.4776. |